Clarius Mobile Health and Trice Medical are partnering to deliver the next generation of what is reportedly the world’s first platform that enables orthopedic physicians to use high-definition wireless ultrasound and a single-use handheld arthroscope on one tablet.
Scheduled for release in early 2023, the new high-definition mi-ultra™ platform, powered by Clarius, will offer physicians two clear ways to dynamically evaluate the anatomy in diverse care settings. It combines mi-eye 3®, the world’s first FDA-cleared single-use 25° arthroscope with Clarius’ high-definition ultrasound, making them accessible through a single tablet.
Clarius handheld wireless ultrasound scanners deliver high-resolution ultrasound images traditionally only available with bulkier, high-end systems at significantly lower cost. The new Trice solution will be available with the Clarius L15 HD3, Clarius L20 HD3, L7 HD3 and the C3 HD3 scanners.
“Our partnership with Clarius helps us take our mi-ultra platform to the next level of performance,” says Mark Foster, President and CEO of Trice Medical. “We’re excited about combining our single-use needle scopes with the best handheld ultrasound solution available on one simple, portable tablet. This is the imaging platform of the future, designed to enable therapeutic extremities procedures to be done in cost effective sites of service. Longer orthopedic procedures should be in the main operating rooms, but any procedure that takes longer to turn over the room than it does to complete the procedure is perfect for our platform.”
Clarius Mobile Health and Trice Medical are partnering to deliver the next generation of what is reportedly the world's first platform that enables orthopedic physicians to use high-definition wireless ultrasound and a single-use handheld arthroscope on one tablet.
Scheduled for release in early 2023, the new high-definition mi-ultra™...
Clarius Mobile Health and Trice Medical are partnering to deliver the next generation of what is reportedly the world’s first platform that enables orthopedic physicians to use high-definition wireless ultrasound and a single-use handheld arthroscope on one tablet.
Scheduled for release in early 2023, the new high-definition mi-ultra™ platform, powered by Clarius, will offer physicians two clear ways to dynamically evaluate the anatomy in diverse care settings. It combines mi-eye 3®, the world’s first FDA-cleared single-use 25° arthroscope with Clarius’ high-definition ultrasound, making them accessible through a single tablet.
Clarius handheld wireless ultrasound scanners deliver high-resolution ultrasound images traditionally only available with bulkier, high-end systems at significantly lower cost. The new Trice solution will be available with the Clarius L15 HD3, Clarius L20 HD3, L7 HD3 and the C3 HD3 scanners.
“Our partnership with Clarius helps us take our mi-ultra platform to the next level of performance,” says Mark Foster, President and CEO of Trice Medical. “We’re excited about combining our single-use needle scopes with the best handheld ultrasound solution available on one simple, portable tablet. This is the imaging platform of the future, designed to enable therapeutic extremities procedures to be done in cost effective sites of service. Longer orthopedic procedures should be in the main operating rooms, but any procedure that takes longer to turn over the room than it does to complete the procedure is perfect for our platform.”
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
